Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$29.00 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF SUMMARY Display this book on your site! Related Titles Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary Evolution of Translational Omics: Lessons Learned and the Path Forward Other Related Titles Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary (2011) Board on Health Sciences Policy (HSP) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Appendix C: Registered Attendees." Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary. Washington, DC: The National Academies Press, 2011. Please select a format: Page 81   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. C Registered Attendees Kevin Anderson DHS Science & Technology George Annas Boston University Naomi Aronson Blue Cross and Blue Shield Technology Evaluation Center LeeAnn Bailey Deloitte LLP Robert Becker U.S. Food and Drug Administration Judith Benkendorf American College of Medical Genetics Jim Black TRICARE Management Activity Bruce Blumberg Kaiser Permanente Denise Bonds National Heart, Lung, and Blood Institute Khaled Bouri U.S. Food and Drug Administration Joel V. Brill Independent Amy Brower American College of Medical Genetics Jonca Bull Novartis Pharmaceuticals Ned Calonge The Colorado Trust Page 81 Front Matter (R1-R20) 1 Introduction (1-4) 2 Stakeholder Perspectives on Evidence (5-24) 3 Approaches to Evidence Generation (25-42) 4 Overcoming Barriers for Evidence Generation (43-52) 5 Considerations Moving Forward (53-58) 6 Final Remarks (59-62) References (63-66) Appendix A: Workshop Agenda (67-70) Appendix B: Speaker Biographical Sketches (71-80) Appendix C: Registered Attendees (81-86)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 81
Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary C Registered Attendees Kevin Anderson DHS Science & Technology George Annas Boston University Naomi Aronson Blue Cross and Blue Shield Technology Evaluation Center LeeAnn Bailey Deloitte LLP Robert Becker U.S. Food and Drug Administration Judith Benkendorf American College of Medical Genetics Jim Black TRICARE Management Activity Bruce Blumberg Kaiser Permanente Denise Bonds National Heart, Lung, and Blood Institute Khaled Bouri U.S. Food and Drug Administration Joel V. Brill Independent Amy Brower American College of Medical Genetics Jonca Bull Novartis Pharmaceuticals Ned Calonge The Colorado Trust

OCR for page 82
Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary Kathryn Camp Office of Dietary Supplements National Institutes of Health Julie Cantor-Weinberg College of American Pathologists A. Egon Cholakian IRDF Project Harvard / Columbia Melina Cimler Illumina Inc. Ralph Coates Centers for Disease Control and Prevention Constanze Coon Deloitte LLP Marsha Deckman Peconic Bay Medical Center Patricia Deverka Center for Medical Technology Policy Melinda DiVito The National Academies Bernard Edelman Vietnam Veterans of America Aled Edwards Structural Genomics Consortium Robert Epstein Medco Health Solutions, Inc. William Gregory Feero National Human Genome Research Institute Amanda Field Genetic Alliance Andrew Freedman National Cancer Institute Gregory Germino National Institute of Diabetes and Digestive and Kidney Diseases Geoffrey Ginsburg Duke University Theresa Gorenc Avalere Health Linda Griffith University of Kansas Medical Center Manjit Hanspal National Institutes of Health Daniel Hayes University of Michigan Comprehensive Cancer Center Peter Henderson PWHenderson Bradford Hirsch Duke University India Hook-Barnard The National Academies Janet Jenkins-Showalter Roche Sharon Kardia University of Michigan School of Public Health

OCR for page 83
Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary Alice Kau National Institute of Child Health and Human Development Alisha Keehn American College of Medical Genetics James Kelly Roche Molecular Systems Mohamed Khan American Medical Association Muin Khoury Centers for Disease Control and Prevention Roger Klein BloodCenter of Wisconsin Pei Koay Chemical Heritage Foundation Hanns Kuttner Hudson Institute Eric Larson Group Health Research Institute Meghan Lawson Cepheid, Inc. Teresa Lee Advanced Medical Technology Association Greg Lennon SNPedia Debra Leonard College of American Pathologists Caryn Lerman University of Pennsylvania Leslie Levin Medical Advisory Secretariat, Ministry of Health & Long-Term Care Hallie Lewis Cepheid, Inc. Adriana Malheiro National Center for Biotechnology Information Elizabeth Mansfield U.S. Food and Drug Administration Robert McCormack Veridex, LLC. Stephen Michael Policy Directions Inc. James Mills National Institutes of Health C. Douglas Monroe Kaiser Permanente Amy Muhlberg Life Technologies Sharon Murphy Institute of Medicine Kathryn Phillips University of California, San Francisco

OCR for page 84
Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary Andre Pilon American Association for Cancer Research Margaret Piper Blue Cross and Blue Shield Technology Evaluation Center Irene Prabhu Das National Cancer Institute Jennifer Puck University of California, San Francisco Elizabeth Rach Institute of Medicine David Ransohoff University of North Carolina at Chapel Hill Lynnie Reid Boston University School of Medicine Wendy Rubinstein NorthShore University Health System Debi Sarkar Maternal and Child Health Bureau Health Resources and Services Administration Thomas Scarnecchia Digital Aurora Sheri Schully National Cancer Institute Fay Shamanski College of American Pathologists Richard Simon National Cancer Institute Scott Steele University of Rochester Robin Stombler Auburn Health Strategies, LLC Fang Sun ECRI Institute Weimin Tang ShanghaiBio (US) Cara Tenenbaum Ovarian Cancer National Alliance Sharon Terry Genetic Alliance Barry Thompson American College of Medical Genetics Martha Turner American Nurses Association Paul Vetter PerkinElmer Michael Watson American College of Medical Genetics Daniel J. Wattendorf Department of the Air Force

OCR for page 85
Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary Meredith Weaver American College of Medical Genetics Catherine Wicklund National Society of Genetic Counselors John Yeh Beth Israel Deaconess Medical Center/Harvard Medical School

OCR for page 86
Generating Evidence for Genomic Diagnostic Test Development: Workshop Summary This page intentionally left blank.